These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25256264)

  • 1. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.
    Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Barburoğlu M
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):219-26. PubMed ID: 25256264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
    Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
    Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.
    Jang JH; Kwon JS; Jang DP; Moon WJ; Lee JM; Ha TH; Chung EC; Kim IY; Kim SI
    Am J Psychiatry; 2006 Jul; 163(7):1202-7. PubMed ID: 16816225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment.
    Lázaro L; Bargalló N; Andrés S; Falcón C; Morer A; Junqué C; Castro-Fornieles J
    Psychiatry Res; 2012 Jan; 201(1):17-24. PubMed ID: 22281202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions.
    Besiroglu L; Sozen M; Ozbebit O; Avcu S; Selvi Y; Bora A; Atli A; Unal O; Bulut MD
    Acta Psychiatr Scand; 2011 Aug; 124(2):141-51. PubMed ID: 21627621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
    Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
    Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
    Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
    Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
    J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
    Sumitani S; Harada M; Kubo H; Ohmori T
    Psychiatry Res; 2007 Jan; 154(1):85-92. PubMed ID: 17208418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
    Ljungberg M; Nilsson MKL; Melin K; Jönsson L; Carlsson A; Carlsson Å; Forssell-Aronsson E; Ivarsson T; Carlsson M; Starck G
    Acta Neuropsychiatr; 2017 Jun; 29(3):179-190. PubMed ID: 27772535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing brain magnetic resonance spectroscopy findings of pediatric treatment-naive obsessive-compulsive disorder patients with healthy controls.
    Yalçın O; Sener S; Konuş Boyunağa OL; Sarıpınar EG; Oğur T; Güney E; Akın Sarı B; Işeri E
    Turk Psikiyatri Derg; 2011; 22(4):222-9. PubMed ID: 22143947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder.
    Ohara K; Isoda H; Suzuki Y; Takehara Y; Ochiai M; Takeda H; Igarashi Y; Ohara K
    Psychiatry Res; 1999 Dec; 92(2-3):83-91. PubMed ID: 10674362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression.
    Bédard MJ; Chantal S
    Psychiatry Res; 2011 Apr; 192(1):45-54. PubMed ID: 21377338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using proton magnetic resonance spectroscopy: a controlled study.
    Kosová E; Pajuelo D; Fajnerová I; Greguš D; Brunovský M; Stopková P; Škoch A; Fürstová P; Španiel F; Horáček J
    BMC Psychiatry; 2023 Oct; 23(1):734. PubMed ID: 37817131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.
    Biria M; Cantonas LM; Banca P
    Curr Top Behav Neurosci; 2021; 49():231-268. PubMed ID: 33751502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls.
    Oner O; Devrimci-Ozguven H; Oktem F; Yagmurlu B; Baskak B; Munir KM
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1494-8. PubMed ID: 17846198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
    Park SE; Choi NG; Jeong GW
    Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of neurofunctional, morphometric and metabolic abnormalities with clinical symptom severity and recognition deficit in obsessive-compulsive disorder.
    Moon CM; Jeong GW
    J Affect Disord; 2018 Feb; 227():603-612. PubMed ID: 29172053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.